Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiu, A. T.Y.
Right arrow Articles by Thompson, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiu, A. T.Y.
Right arrow Articles by Thompson, D. R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:2817-2821, 2003
© 2003 by the American Diabetes Association, Inc.

Epidemiology/Health Services/Psychosocial Research
Original Article

Development of a Reliable and Valid Chinese Version of the Diabetes Empowerment Scale

Ann T.Y. Shiu, MSC, RN1, Rebecca Y.M. Wong, MSC, RN2 and David R. Thompson, PHD, RN1

1 Nethersole School of Nursing, Chinese University of Hong Kong, Hong Kong, China
2 Diabetes & Endocrine Centre, Prince of Wales Hospital, Hong Kong, China

Address correspondence and reprint requests to Ann T.Y. Shiu, The Nethersole School of Nursing, Chinese University of Hong Kong, Shatin, Hong Kong, China. E-mail: annshiu{at}cuhk.edu.hk


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 
OBJECTIVE—To translate the Diabetes Empowerment Scale (DES) into Chinese and establish its psychometric properties among Hong Kong Chinese people.

RESEARCH DESIGN AND METHODS—A two-stage study design, incorporating qualitative and quantitative components, determined the cultural equivalency and content validity of the translated scale and established the psychometric properties of the Chinese DES (C-DES) in 207 patients.

RESULTS—Psychometric analysis supported the reliability and validity of the 20-item Chinese DES (C-DES-20) and five subscales: overcoming barriers ({alpha} = 0.89), determining suitable methods ({alpha} = 0.79), achieving goals ({alpha} = 0.78), obtaining support ({alpha} = 0.78), and coping ({alpha} = 0.76). The test-retest reliability of the intraclass correlations was satifactory when a subsample of 20 patients was tested after a 2-week interval. There was criterion validity between the global scale and metabolic control (HbA1c) of respondents with type 2 diabetes (P = 0.03).

CONCLUSIONS—The C-DES-20 is a reliable and valid outcome measure for patient education and psychosocial interventions among Hong Kong Chinese people with diabetes.

Abbreviations: C-DES, Chinese Diabetes Empowerment Scale • DES, Diabetes Empowerment Scale


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 
Patients with diabetes have to take responsibility for their own care and in the process make many decisions on a daily basis, often with little support and with the burden of having had to overcome social and cultural barriers (1). If the diabetes treatment regimen is to be effective, patients need to actively engage in self-management, and they need to be empowered to accomplish this (2,3). Empowering patients with a sense of control over diabetes is a central theme supported by the World Health Organization, which advocates the importance of fostering psychological well-being as a major outcome (4,5). This shift toward patient empowerment in diabetes education (6,7) is likely to enhance knowledge and cooperation (5,8,9), foster appropriate self-management abilities, and enable patients to overcome some of the personal, social, and environmental barriers that many of them face (10,11). For example, there is evidence that patient empowerment can improve outcomes such as metabolic control and quality of life (8).

Anderson et al. (8), while investigating the application of empowerment with diabetic patients, stated that its purpose was to ensure that patients make informed decisions about their diabetes self-management. Thus, in addition to the knowledge and skills provided by a traditional education program, patients require training in psychosocial skills.

The Diabetes Empowerment Scale (DES) was developed and psychometrically tested among Caucasians (8,12,13). Two versions exist: the long one (DES-37) (12) has 37 items ({alpha} = 0.94) with eight subscales and the short one (DES-28) (13) has 28 items ({alpha} = 0.96) with three subscales. In the past decade, the prevalence of diabetes and, consequently, hospital admissions and mortality rates have risen steadily in Hong Kong (14), spurring diabetologists to advocate the use of empowerment as a model of diabetes care and education (4). It was therefore thought appropriate to develop a version of the DES for a Hong Kong Chinese population. The aim of this study was to translate the DES-37 into Chinese and establish its psychometric properties.


   RESEARCH DESIGN AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
RESULTS
 CONCLUSIONS
 References
 
The study design incorporated qualitative and quantitative components that enabled the psychometric properties of the Chinese measure to be established. This two-stage design followed the procedures of previous work that validated instruments translated for use in different languages and cultures (15–17). The first stage involved the translation of the DES-37 and examination of the newly developed Chinese DES (C-DES) for cultural equivalency and content validity, whereas the second stage established construct validity, criterion validity, internal consistency, and test-retest reliability. Figure 1 depicts the procedures used.



View larger version (20K):
[in this window]
[in a new window]
  		Figure 1— Flow chart for the development and evaluation of the C-DES.

 
Stage 1
The DES-37 was translated into Chinese by a bilingual translator and then translated back into English (back translation) by another bilingual translator. The translation committee (two researchers, two translators, and one research nurse) checked and agreed on a version of the C-DES-37 that best reflected the linguistic and conceptual matter of the original DES-37.

Two focus groups (12 council members of two diabetic patient support groups) were invited as experts to give their opinions on the cultural equivalency of the C-DES-37 and the appropriateness of the language used in the items (18). The two focus group interviews, which lasted ~90 and 120 min, respectively, were audiotaped and transcribed verbatim.

Content analysis of the focus group data was done by two researchers and one research nurse. The analysis showed that the groups’ suggestions were very similar and that only the wording in some items be changed to reflect the colloquial language used by patients in Hong Kong. There was no indication that items needed to be replaced or eliminated. A focus group-modified C-DES-37 was developed accordingly.

A panel of content experts (four diabetologists and four diabetes nurses with expertise in patient education) judged the content validity of the C-DES-37. These experts were also potential users of the scale. The original DES-37 and the focus group-modified C-DES-37 were sent to each member of the content expert panel, who were bilingual. Content validity was assessed by asking the members to rate each item as a valid measure of the construct using a five-point Likert scale (1 = strongly disagree, 5 = strongly agree). A content validity ratio was calculated for each item and for the overall C-DES-37. An acceptable content validity ratio should be >3. The overall ratings were high, attaining a ratio of 4.3 (individual item ratings ranged 4.8–3.9). In addition, the panel was asked to make comments on individual items in relation to the accuracy, clarity, style, and cultural relevance of the translation. Minor changes were suggested (on the fluency of two items), and a panel-modified version was developed.

Stage 2
The panel-modified version of the C-DES-37, together with an additional section on demographic and clinical data, was pilot tested with 19 patients. This was done to check the data collection procedure and the administration of the scale for clarity and patients’ willingness to complete it. A research nurse read the scale in Cantonese, a dialect spoken by >95% of Hong Kong citizens, in a consistent manner and recorded the responses.

The patients in the pilot study initially commented on the nonspecificity of the wording in some of the items involving "diabetes goals." Some patients expected that specific goals within the items would be defined for them. However, it was clarified that the scale was aimed at measuring their own ability to achieve goals set by them rather than those defined by others. After this explanation, the patients found it easy to respond to these nonspecific items. They required an average of 15 min to complete the C-DES-37.

To avoid bias in the main study, a standardized statement was read to each respondent before administering the scale. This statement explained that the purpose of the scale was to measure their ability to cope with psychosocial problems arising from diabetes self-management. Diabetes goals for respondents were not defined. However, they were asked to state their level of agreement on their own ability to identify and achieve such goals. The sequence of the items was also altered. Items that patients regarded as comparatively difficult to respond to were moved to the latter half of the scale, whereas those regarded as easy were placed earlier. The purpose of the resequencing was to avoid discouraging the respondents by having them answer easier questions first and difficult ones later. A postpilot version of the scale was developed.

A diabetes specialist clinic provided the setting for the main study. All patients (type 1 or type 2 diabetic) aged >=18 years who attended the clinic during the 3-month data collection period provided the sampling frame. A sample size of >=185 patients was required to provide a minimum of five respondents per item on the C-DES-37 for factor analysis purposes (19–21). Systematic random sampling was used to select every fourth patient from a printed follow-up appointment list. Those with language problems, such as stroke patients who exhibited speech difficulties, were excluded from the study.

Patients were contacted by telephone by a research nurse 1 week ahead of their clinic visit to explain the nature and purpose of the study, assure confidentiality of personal data, and inform them of their right to withdraw from the study at any time without jeopardizing their care. After obtaining verbal consent, the research nurse set up an appointment with each patient for a structured interview on the same day as the follow-up visit. HbA1c results taken on the follow-up visit were retrieved from the patient’s record.

Analysis
Descriptive statistics were used to establish the frequency, range, mean, and SD of demographic and clinical characteristics of the main sample. Factor analysis was used to determine the construct validity of the scale. As in the original DES study (13), a principal components factor analysis using varimax rotation was used to identify an empirically derived set of subscales. Factor loadings >=0.50 were considered significant and were used to define factors. An iterative process of factor and item analyses was used to compare various forced factor solutions to determine the smallest number of factors that were psychologically coherent and meaningful. The identified factors should have the smallest number of items with a coefficient >=0.70.

Pearson correlation coefficients were performed to examine the relationships among the final C-DES subscales identified from the analysis, and between the final C-DES, the C-DES-37, and the C-DES-28 (the 28 items comprising the short version of the DES were included among the 37 items of the long version, the C-DES-37). A Cronbach’s {alpha}-coefficient was calculated for each subscale and the overall final C-DES to determine internal consistency.

Test-retest reliability using intraclass correlation coefficients was evaluated with a 2-week interval between tests, with a subsample of 20 patients who participated in the main study. This time period was selected with the expectation that it was short enough that empowerment would be unlikely to change but long enough to minimize the risk of eliciting responses that were recalled from prior testing.

Pearson correlation coefficients between HbA1c and the final C-DES were calculated to establish the criterion validity of the scale. HbA1c was selected as a criterion based on the assumption that people with high empowerment would exhibit better self-management, resulting in better metabolic control (8). Reverse scores were performed for all items of the C-DES so that a high DES score signified high empowerment (1 = strongly disagree, 5 = strongly agree).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
CONCLUSIONS
 References
 
Demographic and clinical data
Of the 298 total patients identified from the appointment list, 52 refused to participate, 25 could not be contacted, and 14 did not keep their appointment. Thus, the main sample consisted of 207 patients (response rate = 70%). A goodness-of-fit {chi}2 test revealed no statistically significant differences between the respondents and nonrespondents in terms of age and sex.

Table 1 displays the demographic and clinical data of the respondents. The majority were aged between 46 and 65 years (53 ± 12.4 [mean ± SD]). Most (83%) had type 2 diabetes, one-third (30%) had diabetes diagnosed within the past 5 years, and another one-third (31%) had optimal metabolic control according to World Health Organization criteria (22).


View this table:
[in this window]
[in a new window]
  		Table 1— Demographic and clinical data

 
Psychometric tests and scale statistics
Factor analysis yielded 11 factors with Eigen values >=1.0. After an iterative process of factor and item analyses, a five-factor solution was judged the best. This yielded a 20-item C-DES (C-DES-20; {alpha} = 0.86) with five subscales accounting for 63.3% of the total variance. Descriptive statistics for the subscales are presented in Table 2, and a list of their items are displayed in Table 3.


View this table:
[in this window]
[in a new window]
  		Table 2— Descriptive statistics for C-DES-20 subscales

 

View this table:
[in this window]
[in a new window]
  		Table 3— Items of the five subscales of C-DES-20

 
The correlations among the five subscales ranged between 0.34 and 0.63. The C-DES-20 test-retest reliability using intraclass correlation coefficients of a subsample of patients (n = 20; mean age 51 ± 11.5 years) was 0.75 (95% CI 0.43–0.91). The coefficients among the subscales ranged from 0.73 to 0.83 (95% CI 0.40–0.94).

The correlation of the C-DES-20 with the C-DES-37 and the C-DES-28 is 0.95 and 0.93, respectively. No significant correlation was found among the five subscales, the global scale, and HbA1c in the main sample. When the main sample was categorized into respondents with type 1 (n = 36) and type 2 (n = 171) diabetes, a significant correlation was found between the global scale and HbA1c of type 2 respondents (-0.17, P = 0.03), indicating that the higher the C-DES scores, the lower the HbA1c values. All other correlations were not significant. After controlling for the effects of age, educational level, and length of time since diabetes diagnosis, the correlation between global empowerment and HbA1c of type 2 diabetic respondents remained significant but was not significant for type 1 diabetic respondents.


   CONCLUSIONS
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
References
 
The findings of this study provide support for the construct validity and test-retest reliability of the C-DES-20. The {alpha}-coefficient for the five subscales and the global C-DES-20 was good. The strength of the intercorrelations among the C-DES-20 subscales suggests that the instrument measures related but separate domains of empowerment (23). The test-retest reliability of the C-DES-20 was supported by the intraclass correlation of the subsample of 20 patients when tested after a period of 2 weeks.

However, criterion validity was not supported by most correlations among the C-DES-20 subscales, global scale, and HbA1c. Only a weak correlation was found between global scale and HbA1c of respondents with type 2 diabetes. The lack of significant correlations may have been caused by the adoption of an undifferentiated sample. The U.K. Prospective Diabetes Study (24) demonstrated that no matter which treatment regime patients with type 2 diabetes received, the subjects’ metabolic control deteriorated over time. In the current study, although the effect of the duration of diabetes was statistically controlled for in the data analysis, this could not circumvent the fact that many type 2 diabetic patients may have had undiagnosed diabetes for a long time prior. It is of interest that a cross-sectional study (25) with American veterans (n = 90) also demonstrated a lack of correlation between metabolic control and DES-37.

Given the limited empirical findings in the measurement of empowerment among Chinese people with diabetes, the C-DES-20 has potential as an outcome measure for patient education and health promotion. Considering its brevity and ease of administration, the C-DES-20 can be used to identify patients who are less capable of dealing with diabetes-specific psychosocial problems and require special attention. Further study with different Chinese populations will be required to confirm the factor structure of the scale.


   Acknowledgments
 
This research was funded by the Health Care and Promotion Fund.


   Footnotes
 
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

Received for publication February 17, 2003. Accepted for publication July 17, 2003.


   References
TOP
 ABSTRACT
 INTRODUCTION
 RESEARCH DESIGN AND METHODS
 RESULTS
 CONCLUSIONS
 References
 

  1. Humphry J, Jameson LM, Beckham S: Overcoming social and cultural barriers to care for patients when the diagnosis is diabetes. West J Med 167:138–144, 1997[Medline]
  2. Hunt LM, Pugh J, Valenzuela M: How patients adapt diabetes self-care recommendations in everyday life. J Fam Pract 3:207–215, 1998
  3. Glasgow RE, Osteen VL: Evaluating diabetes education: are we measuring the most important outcomes? Diabetes Care 15:1423–1432, 1992[Abstract]
  4. Bradley C, Gamsu DS: Guidelines for encouraging psychological well being: report of a working group of the World Health Organization Regional Office for Europe and International Diabetes Federation European Region St. Vincent Declaration Action Programme for Diabetes. Diabet Med 11:510–516, 1994[Medline]
  5. Tones K: Health education and the promotion of health: seeking wisely to empower. In Health and Empowerment: Research and Practice. Kendall S, Ed. London, Arnold, 1998, p. 57–90
  6. Chan JCN, Yeung VTF, Chow CC, Ko GTC, Cockram CS: A Manual for Management of Diabetes Mellitus: a Hong Kong Chinese Perspective. Hong Kong, China, Chinese Univ. Press, 1998
  7. Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, Taylor-Moon D, White NH: Empowerment: an idea whose time has come in diabetes education. Diabetes Educ 17:37–41, 1991
  8. Anderson RM, Arnold MS, Funnell MM, Fitzgerald JT, Bulter PM, Feste C: Patient empowerment: results of a randomized controlled trial. Diabetes Care 18:943–949, 1995[Abstract]
  9. Ary DV, Toober D, Wilson W, Glasgow RE: Patient perspective on factors contributing to nonadherence to diabetes regimen. Diabetes Care 9:168–172, 1986[Abstract]
  10. Shiu ATY, Wong RYM: Fear of hypoglycemia among insulin-treated Hong Kong Chinese patients: implications for diabetes education. Pat Ed Counsel 41:251–261, 2000
  11. Glasgow RE, Hampson S, Strycker L, Riggiero L: Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care 20:556–561, 1997[Abstract]
  12. Anderson RM, Fitzgerald JM, Funnell M, Feste C: Diabetes empowerment scale (DES): a measure of psychosocial self-efficacy (Abstract). Diabetes 46 (Suppl. 1):269A, 1997
  13. Anderson RM, Funnell MM, Fitzgerald JT, Marrero DG: Diabetes empowerment scale: a measure of psychosocial self-efficacy. Diabetes Care 23:739–743, 2000[Abstract/Free Full Text]
  14. Chan JCN, Yeung VTF, Chow CC, Cockram CS: Diabetes mellitus: epidemiology and pathogenesis. Hong Kong Practitioner 18:270–279, 1996
  15. Guillemin F, Bombardier D, Beaton D: Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46:1417–1432, 1993[Medline]
  16. Bradley C: Translation of questionnaires for use in different languages and cultures. In Handbook of Psychology and Diabetes: a Guide to Psychological Measurement in Diabetes Research and Management. Bradley C, Ed. Langhorne, PA, Harwood Academic Publishers, 1994, p. 43–56
  17. Bracken BA, Barona A: State of the art procedures for translating, validating and using psychoeducational tests in cross-cultural assessment. School Psychol Int 12:119–132, 1991
  18. Twinn S: An analysis of the effectiveness of focus groups as a method of qualitative data collection with Chinese populations in nursing research. J Adv Nurs 28:654–661, 1998[Medline]
  19. Nunnally JC: Psychometric Theory. 3rd ed. New York, McGraw-Hill, 1978
  20. McDowell L, Newell C: Measuring Health: a Guide to Rating Scales and Questionnaires. New York, Oxford Univ. Press, 1987
  21. Streiner DL, Norman GR: Health Measurement Scales: a Practical Guide to Their Development and Use. 2nd ed. Oxford, U.K., Oxford Univ. Press, 1995
  22. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
  23. Boyle GJ: Does item homogeneity indicate internal consistency or item reduncy in psychometric scales? Pers Individ Dif 12:291–294, 1990
  24. U.K. Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837–853, 1998[Medline]
  25. Via PS, Salyer J: Psychosocial self-efficacy and personal characteristics of veterans attending a diabetes education programme. Diabetes Educ 25:727–734, 1999[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Diabetes CareHome page
A. T.Y. Shiu
National Standards for Diabetes Self-Management Education: Response to Funnell et al.
Diabetes Care, November 1, 2007; 30(11): e116 - e116.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
A. T.Y. Shiu, S.-m. Li, and D. R. Thompson
The Concurrent Validity of the Chinese Version of the Diabetes Empowerment Scale
Diabetes Care, February 1, 2005; 28(2): 498 - 499.
[Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shiu, A. T.Y.
Right arrow Articles by Thompson, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shiu, A. T.Y.
Right arrow Articles by Thompson, D. R.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum